|
1
|
Liberal R, Grant CR, Mieli-Vergani G and
Vergani D: Autoimmune hepatitis: A comprehensive review. J
Autoimmun. 41:126–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liberal R, Mieli-Vergani G and Vergani D:
Clinical significance of autoantibodies in autoimmune hepatitis. J
Autoimmun. 46:17–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krawitt EL: Autoimmune hepatitis. N Engl J
Med. 354:54–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oketani M, Ido A, Nakayama N, Takikawa Y,
Naiki T, Yamagishi Y, Ichida T, Mochida S, Onishi S and Tsubouchi
H: Intractable Hepato-Biliary Diseases Study Group Of Japan:
Etiology and prognosis of fulminant hepatitis and late-onset
hepatic failure in Japan: Summary of the annual nationwide survey
between 2004 and 2009. Hepatol Res. 43:97–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Czaja AJ: Acute and acute severe
(fulminant) autoimmune hepatitis. Dig Dis Sci. 58:897–914. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Montano Loza, Carpenter HA and Czaja AJ:
Predictive factors for hepatocellular carcinoma in type 1
autoimmune hepatitis. Am J Gastroenterol. 103:1944–1951. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshizawa K, Matsumoto A, Ichijo T,
Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M,
Katsuyama Y, et al: Long-term outcome of Japanese patients with
type 1 autoimmune hepatitis. Hepatology. 56:668–676. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bowlus CL and Gershwin ME: The diagnosis
of primary biliary cirrhosis. Autoimmun Rev. 13:441–444. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kakuda Y, Harada K, Sawada-Kitamura S,
Ikeda H, Sato Y, Sasaki M, Okafuji H, Mizukoshi E, Terasaki S, Ohta
H, et al: Evaluation of a new histologic staging and grading system
for primary biliary cirrhosis in comparison with classical systems.
Hum Pathol. 44:1107–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Manns MP, Czaja AJ, Gorham JD, Krawitt EL,
Mieli-Vergani G, Vergani D and Vierling JM: American Association
For The Study Of Liver Diseases: Diagnosis and management of
autoimmune hepatitis. Hepatology. 51:2193–2213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Verslype C, George C, Buchel E, Nevens F,
van Steenbergen W and Fevery J: Diagnosis and treatment of
autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther.
21:695–699. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chantran Y, Ballot É and Johanet C:
Autoantibodies in primary biliary cirrhosis: Antimitochondrial
autoantibodies. Clin Res Hepatol Gastroenterol. 37:431–433. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindor KD, Gershwin ME, Poupon R, Kaplan
M, Bergasa NV and Heathcote EJ: American Association For Study Of
Liver Diseases: Primary biliary cirrhosis. Hepatology. 50:291–308.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gershwin ME, Mackay IR, Sturgess A and
Coppel RL: Identification and specificity of a cDNA encoding the 70
kd mitochondrial antigen recognized in primary biliary cirrhosis. J
Immunol. 138:3525–3531. 1987.PubMed/NCBI
|
|
15
|
Czaja AJ, Carpenter HA, Santrach PJ, Moore
SB and Homburger HA: The nature and prognosis of severe cryptogenic
chronic active hepatitis. Gastroenterology. 104:1755–1761.
1993.PubMed/NCBI
|
|
16
|
Moteki S, Leung PS, Dickson ER, Van Thiel
DH, Galperin C, Buch T, Alarcon-Segovia D, Kershenobich D, Kawano
K, Coppel RL, et al: Epitope mapping and reactivity of
autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase
complex in primary biliary cirrhosis using recombinant
2-oxoglutarate dehydrogenase complex. Hepatology. 23:436–444. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gershwin ME, Rowley M, Davis PA, Leung P,
Coppel R and Mackay IR: Molecular biology of the 2-oxo-acid
dehydrogenase complexes and anti-mitochondrial antibodies. Prog
Liver Dis. 10:47–61. 1992.PubMed/NCBI
|
|
18
|
Leung PS, Chuang DT, Wynn RM, Cha S,
Danner DJ, Ansari A, Coppel RL and Gershwin ME: Autoantibodies to
BCOADC-E2 in patients with primary biliary cirrhosis recognize a
conformational epitope. Hepatology. 22:505–513. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamagiwa S, Kamimura H, Takamura M and
Aoyagi Y: Autoantibodies in primary biliary cirrhosis: Recent
progress in research on the pathogenetic and clinical significance.
World J Gastroenterol. 20:2606–2612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto K, Terada R, Okamoto R, Hiasa Y,
Abe M, Onji M and Tsuji T: A scoring system for primary biliary
cirrhosis and its application for variant forms of autoimmune liver
disease. J Gastroenterol. 38:52–59. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farias AQ, Gonçalves LL, Bittencourt PL,
De Melo ES, Abrantes-Lemos CP, Porta G, Nakhle MC, Carrilho FJ and
Cancado EL: Applicability of the IAIHG scoring system to the
diagnosis of antimitochondrial/anti-M2 seropositive variant form of
autoimmune hepatitis. J Gastroenterol Hepatol. 21:887–893. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suzuki A, Brunt EM, Kleiner DE, Miquel R,
Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K and
Björnsson E: The use of liver biopsy evaluation in discrimination
of idiopathic autoimmune hepatitis versus drug-induced liver
injury. Hepatology. 54:931–939. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alvarez F, Berg PA, Bianchi FB, Bianchi L,
Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet
VJ, et al: International autoimmune hepatitis group report: Review
of criteria for diagnosis of autoimmune hepatitis. J Hepatol.
31:929–938. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chazouilleres O, Wendum D, Serfaty L,
Montembault S, Rosmorduc O and Poupon R: Primary biliary
cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features
and response to therapy. Hepatology. 28:296–301. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dellavance A, Cancado EL, Abrantes-Lemos
CP, Harriz M, Marvulle V and Andrade LE: Humoral autoimmune
response heterogeneity in the spectrum of primary biliary
cirrhosis. Hepatol Int. 7:775–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miyakawa H, Kitazawa E, Fujikawa H,
Kikuchi K, Abe K, Kawaguchi N and Kako M: Analysis of two major
anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary
cirrhosis: Relationship to titers of immunofluorescent
anti-mitochondrial antibody. Hepatol Res. 18:1–9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yanagawa T, Miyakawa H, Shibata M,
Kawaguchi N, Ishibashi M, Goto N and Mitamura K: Immunoreactivity
to pyruvate dehydrogenase complex-E2 in well-defined patients with
autoimmune hepatitis: Western blot analysis. Hepatol Res. 26:81–86.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roda A, Pasini P, Guardigli M, Baraldini
M, Musiani M and Mirasoli M: Bio- and chemiluminescence in
bioanalysis. Fresenius J Anal Chem. 366:752–759. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Brien C, Joshi S, Feld JJ, Guindi M,
Dienes HP and Heathcote EJ: Long-term follow-up of
antimitochondrial antibody-positive autoimmune hepatitis.
Hepatology. 48:550–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
